Sionna Therapeutics, Inc. Common Stock (SION)

Sionna Therapeutics, Inc. Common Stock (SION) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $187M; returns 1 day -5.3%, 1 week -7.5%, 1 year -90.9%.

Sionna Therapeutics, Inc. (SION) is a clinical-stage biopharmaceutical company focused on revolutionizing cystic fibrosis (CF) treatment by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein.

Groups SION belongs to

• Biotechnology
• Cystic Fibrosis Therapies
• Healthcare
• Biopharmaceutical
• Clinical Stage Biotech
• Pharmaceuticals
• Clinical Stage Biopharma
• Clinical Stage
• Life Sciences
• Rare Diseases
• Drug Discovery

SION financial model: income statement, cash flow and balance sheet